Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma
X Ren, Y Zhang, YI Lyu, B Jin, H Guo, J Wu… - Cancer …, 2019 - content.iospress.com
BACKGROUND: No tumor biomarker (TM) is available for de novo metastatic lung
adenocarcinoma. OBJECTIVE: To examine the serum levels of carcinoembryonic antigen …
adenocarcinoma. OBJECTIVE: To examine the serum levels of carcinoembryonic antigen …
Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation
A Pissaia Jr, D Bernard, O Scatton, O Soubrane… - Transplantation …, 2009 - Elsevier
Tumor markers are elevated in a variety of nonneoplastic clinical situations, including liver
diseases. Their sensitivity and specificity are lower for tumor screening in these cases. In this …
diseases. Their sensitivity and specificity are lower for tumor screening in these cases. In this …
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer
L Giovanella, L Ceriani, M Bandera… - … journal of biological …, 1995 - journals.sagepub.com
We investigated the role of tumor markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer
diagnosis and staging in 169 patients with histologically confirmed lung cancer (43 SCLC …
diagnosis and staging in 169 patients with histologically confirmed lung cancer (43 SCLC …
Serum CA153 as biomarker for cancer and noncancer diseases
X Li, Y Xu, L Zhang - Progress in molecular biology and translational …, 2019 - Elsevier
CA153 was originally discovered as a tumor antigen recognized by two monoclonal
antibodies DF3 and 115D8 simultaneously. Subsequent studies showed that DF3 …
antibodies DF3 and 115D8 simultaneously. Subsequent studies showed that DF3 …
Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
MJ Gaspar, M Diez, A Rodriguez, T Ratia… - Anticancer …, 2003 - europepmc.org
Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small
cell lung cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
cell lung cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
[HTML][HTML] Elevated serum S100A9 indicated poor prognosis in hepatocellular carcinoma after curative resection
J Meng, F Gu, H Fang, B Qu - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Background: Previous studies suggest S100A9 is a promising biomarker for prognosis in
cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum …
cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum …
Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain
H Zhang, Y Wang, Y Chen, S Sun, N Li, D Lv, C Liu… - Lung Cancer, 2007 - Elsevier
To identify potential markers associated with non-small cell lung cancer (NSCLC) metastasis
to brain, comparative proteome analysis on two lung squamous cell carcinoma (SCC) cell …
to brain, comparative proteome analysis on two lung squamous cell carcinoma (SCC) cell …
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancer
V Liska, L HOLUBEC, V Treska, J Vrzalova… - Anticancer …, 2011 - ar.iiarjournals.org
Aim: The liver is the site of breast cancer metastasis in 50% of patients with advanced
disease. Tumour markers have been demonstrated as being useful in follow-up of patients …
disease. Tumour markers have been demonstrated as being useful in follow-up of patients …
[HTML][HTML] CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow …
Background The aim of this study was to evaluate the value of CA15-3 for the diagnostic
integration of molecular imaging findings performed with hybrid positron emission …
integration of molecular imaging findings performed with hybrid positron emission …
[HTML][HTML] Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective …
O Arrieta, D Saavedra-Perez, R Kuri, A Aviles-Salas… - BMC cancer, 2009 - Springer
Background Central nervous system is a common site of metastasis in NSCLC and confers
worse prognosis and quality of life. The aim of this prospective study was to evaluate the …
worse prognosis and quality of life. The aim of this prospective study was to evaluate the …